Compare WHLR & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHLR | GCTK |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.7K | 225.1K |
| IPO Year | 2011 | 2011 |
| Metric | WHLR | GCTK |
|---|---|---|
| Price | $0.24 | $2.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 2.5M |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.64 | N/A |
| EPS | N/A | ★ 2.44 |
| Revenue | ★ $99,445,000.00 | $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.21 | $0.28 |
| 52 Week High | $8.71 | $103.50 |
| Indicator | WHLR | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 40.36 | 47.69 |
| Support Level | $0.21 | $0.28 |
| Resistance Level | $0.57 | $3.25 |
| Average True Range (ATR) | 0.07 | 0.33 |
| MACD | -0.04 | 0.20 |
| Stochastic Oscillator | 0.86 | 44.76 |
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Cypress Shopping Center in Boiling Springs, South Carolina, and others.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.